RAPPER
24 Nov 2020
Trial Summary
REVIEW OF AUSTRALIAN PRESCRIBING PRACTICES OF ERIBULIN
Acronym:
RAPPER
ACTRN/NCT /ethics:
N/A
Scientific title:
REVIEW OF AUSTRALIAN PRESCRIBING PRACTICES OF ERIBULIN
Sponsor / Cooperative group:
N/A
Trial & Patient Characteristics
| Cancer Type | All cancers |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | All phases |
| Age Range | - |
| Sex | - |
| Tumour Stream | - |
| Cancer Stage | All stages |
| Anticipated Start Date | - |
| Anticipated End Date | - |
Participating Hospitals
| Hospital | Ashford Cancer Centre Research |
|---|---|
| Clinical Trial Coordinator | Sue Yeend |
| syeend@adelaidecancercentre.com.au | |
| Phone | 08 8292 2240 |
| Principal Investigator | Dr Kerry Cheong |
| Recruitment Status | Recruiting |